poisar

Stocks · News reference

Zebra Technologies To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Analysts cut Exodus’ target, raised targets for Teledyne, Roblox, Scholar Rock, Zebra, Agilon, SM Energy and Paymentus; Agilon upgraded to Outperform.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

AGLENVAEXODMURPAYRBLXSMSRRKTDYZBRA
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Delveinsight

    Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

    The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

    UNHHUMEVHAGLPRVA
  4. SEC EDGAR

    8-K filing — Enova International, Inc. (ENVA)

    Filed: 2026-09-17 AccNo: 0001193125-26-394356 Size: 155 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

    ENVA
  5. Glancy Prongay Wolke & Rotter Llp

    Securities Fraud Investigation Into Enova International, Inc. (ENVA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

    Enova International withdrew its applications to become a bank holding company through the acquisition of Grasshopper Bancorp on September 14, 2026, citing unclear regulatory standards and political pressure. The announcement caused Enova shares to fall 23.43% to $173.61, prompting a securities fraud investigation by Glancy Prongay Wolke & Rotter LLP on behalf of affected shareholders.

    ENVA